Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$123.41 0.28 | 0.23%
06/23/17 - 10:26 AM ET
Company Profile
Price and Volume
Recent Price 123.13
52 Week High 139.79
52 Week Low 87.50
Avg. Daily Vol. (Mil) 0.22
Beta (3 year) 1.06
Share Related Items
Mkt Cap (Mil) 2,585.24
Shares Out (Mil) 21.00
Float (Mil) 17.78
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.70
Current Ratio 0.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.62
Valuation Ratios
Price Earnings n.a.
Price/Sales 23.72
Price/Book 7.57
Price/Cash Flow 123.50
Per Share Data
Earnings -0.07
Sales 5.19
Book Value 16.25
Cash Flow 1.00
Business Summary
Ligand Pharmaceuticals Inc is a biopharmaceutical company. Its business model is based upon the concept of acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure.
General Information
3911 Sorrento Valley Bouleva
Suite 110
San Diego, CA 92037
www.ligand.com
Industry : Drugs
Sector: Health Care
Employees: 22
CEO: Mr. John L. Higgins
Short Interest
Current Month (Mil) 5.19
Previous Month (Mil) 5.10
Short Interest Ratio (Days) 25.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -0.30
Return on Investments -0.50
Profitability
Gross Margin 94.90
EBIT Margin 7.50
Profit Margin -1.50

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter